Burden of congenital rubella syndrome after a
community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001
TATIANA M. LANZIERI, MD; T. CRISTINA SEGATTO, RN; MARILDA M. SIQUEIRA,
PhD; ELIZABETH C. DE OLIVEIRA SANTOS, MD; LI JIN, PhD; D. REBECCA PREVOTS,
PhD, MPH*
Background.
During 1999 and 2000 rubella outbreaks were
reported in 20 of 27 states in Brazil, many among young adults. We
investigated a large rubella outbreak in Rio Branco, Acre, in northwestern
Brazil, where rubella vaccination targeting children 1 to 11 years old had
been introduced in April 2000. Surveillance for congenital rubella
syndrome (CRS) was initiated after the outbreak.
Methods.
Suspected rubella cases were detected through
active and passive surveillance. Confirmed rubella cases were patients
with fever, rash and rubella-specific IgM antibodies. Suspected CRS cases
were infants born with CRS-compatible defects or born to mothers with a
history of rubella during pregnancy. Confirmed cases were infants with
CRS-compatible defects and rubella-specific IgM antibodies.
Results.
From April 1 to December 31, 2000, 391
confirmed rubella cases were reported. The incidence among persons ages 12
to 19 years (3.3 per 1000 population) was increased 3.7-fold relative to
children ages 1 to 4 years (95% confidence interval, 2.4 to 5.8). Of 21
infants with suspected CRS cases, 17 (91%) were tested for
rubella-specific antibodies, of whom 7 were IgM-positive and 5 had
confirmed CRS. The peak incidence of confirmed CRS (4.3 per 1000) was in
March 2001, 7 months after the outbreak peak, with an annualized incidence
of 0.6 per 1000.
Conclusions.
Vaccination among school age children was
insufficient to prevent a rubella outbreak among young adults that
resulted in the occurrence of at least 5 cases of CRS. To prevent further
cases of CRS, outbreak vaccination of young adults was conducted in
November 2000 and among women ages 12 to 39 years in 2001 as part of a
national campaign, with a coverage of 98% statewide.
From the National Epidemiology
Center, National Health Foundation, Ministry of Health (TML,
CS), and the Pan American Health Organization (RP), Brasília, Brazil; Department of
Virology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro,
Brazil (MMS); Evandro Chagas Institute, Ministry of Health,
Belém, Brazil (ECdOS);
and Central Public Health Laboratory, London, UK (LJ).
Accepted for publication Dec. 6,
2002.
*Current address: Centers for
Disease Control and Prevention, National Immunization Program,
1600 Clifton Rd., MS E-05, Atlanta, GA 30333.
Address for reprints: D. Rebecca
Prevots, M.D., Centers for Disease Control and Prevention,
National Immunization Program, 1600 Clifton Rd., MS E-05,
Atlanta, GA 30333. Fax 404-639-8573; E-mail rprevots@cdc.gov.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"